Glaucoma, Neovascular

A form of secondary glaucoma which develops as a consequence of another ocular disease and is attributed to the forming of new vessels in the angle of the anterior chamber.

Drugs by status

Phase 4 trials (1)

ranibizumab

Phase 3 trials (4)

aganirsen
mitomycin
collagen
aflibercept

Phase 2 trials (6)

potassium chloride
sodium acetate
zinc dichloride
sodium chloride
magnesium
kdr2-2

Phase 1 trials (1)

pegaptanib

Other trials (2)

travoprost
bevacizumab

Organizations

Organization Involved with Phase 4 Indications (4)

Mahidol University
Siriraj Hospital
Jiao Tong University
Ningbo University

Organization Involved with Phase 3 Indications (10)

Regeneron
Novartis
Bayer
Gene Signal SAS
Pro Top & Mediking Company Limited
University of London
University of Tartu
University of Cologne
University of Sao Paulo
Johannes Gutenburg University

Organization Involved with Phase 2 Indications (10)

Genentech
Bascom Palmer Eye Institute
California Retina Consultants
University of Maryland
Asociación para Evitar la Ceguera en México
University of California, San Francisco
University of Colorado, Denver
Sun Yat-Sen University
University of North Carolina at Chapel Hill
University of Illinois at Chicago

Organization Involved with Other Experimental Indications (2)

Shahid Beheshti University of Medical Sciences
University of Lubeck